Thomasville, North Carolina Clinical Trials

A listing of Thomasville, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
featured
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.

A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the investigational medication, a currently approved Crohn’s medication, or placebo. The study comprises four periods: screening, treatment period 1, treatment period 2, …

gastrointestinal disorder
inflammatory bowel disease
crohn's disease
gastrointestinal diseases
VIVID-1 Study Center
 (7.3 away) Contact site
  • 66 views
  • 02 Aug, 2021
  • +75 other locations
Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19

A Phase 3 randomized, multi-center, open label study to assess the efficacy, safety, and tolerability of monoclonal antibody VIR-7831 (sotrovimab) given intramuscularly versus intravenously for the treatment of mild/moderate coronavirus disease 2019 (COVID-19) in high-risk non-hospitalized patients

Investigative Site
 (7.2 away) Contact site
  • 1 views
  • 01 Aug, 2021
  • +66 other locations
A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

The primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).

Galderma Investigational Site
 (7.2 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +140 other locations
An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis

The primary objective is to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.

Galderma Investigational Site
 (7.2 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +84 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
Dermatology Consulting Services
 (8.3 away) Contact site
  • 717 views
  • 27 Jul, 2021
  • +354 other locations
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.

trabeculectomy
intraocular pressure
brimonidine tartrate ophthalmic solution
glaucoma
selective laser trabeculoplasty
Cornerstone Eye Care
 (8.3 away) Contact site
  • 3 views
  • 21 Jul, 2021
  • +130 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

iron
heart failure
ejection fraction
nt-probnp
nesiritide
Wake Forest University Health Sciences
 (8.3 away) Contact site
  • 5316 views
  • 02 Aug, 2021
  • +365 other locations
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such …

trastuzumab
ejection fraction
hepatitis c virus
hcv viral load
estrogen receptor
Novant Health Cancer Institute - Thomasville
 (0.9 away) Contact site
  • 43 views
  • 01 Aug, 2021
  • +576 other locations
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase II/III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

Novant Health Cancer Institute - Thomasville
 (0.9 away) Contact site
  • 135 views
  • 04 Aug, 2021
  • +539 other locations
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the …

hepatitis
combination chemotherapy
hysterectomy
ct scan
immunosuppressive
Novant Health Oncology Specialists-Davidson County
 (0.9 away) Contact site
  • 68 views
  • 04 Aug, 2021
  • +507 other locations